BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 18479601)

  • 1. [Sleeve resection for lung cancer: a report of 82 cases].
    Chen PC; Zhou XM; Chen QX; Liu JS; Yan FL; Jiang YH
    Ai Zheng; 2008 May; 27(5):510-5. PubMed ID: 18479601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study on perioperative risks and functional results in bronchial and bronchovascular sleeve resections.
    Schirren J; Bölükbas S; Bergmann T; Fisseler-Eckhoff A; Trainer S; Beqiri S
    Thorac Cardiovasc Surg; 2009 Feb; 57(1):35-41. PubMed ID: 19169995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
    Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
    Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ; Han F; Gao SL; A DL; Pang ZL
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy.
    Kim YT; Kang CH; Sung SW; Kim JH
    Ann Thorac Surg; 2005 Apr; 79(4):1153-61; discussion 1153-61. PubMed ID: 15797043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection of tracheal carina for lung cancer. Procedure, complications, and mortality.
    Tsuchiya R; Goya T; Naruke T; Suemasu K
    J Thorac Cardiovasc Surg; 1990 May; 99(5):779-87. PubMed ID: 2329816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
    Huang GJ; Fang DK; Cheng GY; Zhang DC
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chest wall invasion in carcinoma of the lung. Therapeutic and prognostic implications.
    McCaughan BC; Martini N; Bains MS; McCormack PM
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):836-41. PubMed ID: 2987619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
    Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
    Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma.
    Ludwig C; Stoelben E; Olschewski M; Hasse J
    Ann Thorac Surg; 2005 Mar; 79(3):968-73. PubMed ID: 15734415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleeve lobectomy for carcinoma of the lung.
    Weisel RD; Cooper JD; Delarue NC; Theman TE; Todd TR; Pearson FG
    J Thorac Cardiovasc Surg; 1979 Dec; 78(6):839-49. PubMed ID: 228125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleeve lobectomy for patients with non-small cell lung cancer.
    Hanagiri T; Baba T; Ichiki Y; Yasuda M; Sugaya M; Ono K; Uramoto H; Takenoyama M; Yasumoto K
    Int J Surg; 2010; 8(1):39-43. PubMed ID: 19850158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences.
    Deslauriers J; Grégoire J; Jacques LF; Piraux M; Guojin L; Lacasse Y
    Ann Thorac Surg; 2004 Apr; 77(4):1152-6; discussion 1156. PubMed ID: 15063224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
    Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
    Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.